Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1969 2
1970 3
1971 3
1972 7
1973 6
1974 2
1975 7
1976 5
1977 10
1978 8
1979 4
1980 6
1981 2
1982 5
1983 4
1984 21
1985 15
1986 11
1987 12
1988 18
1989 14
1990 24
1991 14
1992 11
1993 14
1994 26
1995 34
1996 10
1997 9
1998 11
1999 6
2000 7
2001 9
2002 4
2003 2
2004 5
2005 8
2006 5
2007 8
2008 3
2009 3
2010 8
2011 8
2012 2
2013 2
2014 2
2015 1
2016 2
2017 2
2019 2
2020 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

406 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of Cholestyramine 15% Ointment in Relieving Pruritus and Burning After Ileostomy: A Rrandomized, Double-Blind Placebo-Controlled Clinical Trial.
Ala S, Alvandipour M, Saeedi M, Seyedein S, Monajati M, Koulaeinejad N. Ala S, et al. J Invest Surg. 2020 Oct;33(9):795-802. doi: 10.1080/08941939.2019.1578442. Epub 2019 Mar 20. J Invest Surg. 2020. PMID: 30892108 Clinical Trial.
This clinical trial was performed to evaluate the efficacy of topical cholestyramine (15%) on the reduction of the levels of burning and pruritus after an ileostomy. ...Therefore, 30 patients were included in the study. The levels of burning among patients in the choles …
This clinical trial was performed to evaluate the efficacy of topical cholestyramine (15%) on the reduction of the levels of burning …
Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.
Nikkila EA, Miettinen TA, Lanner A. Nikkila EA, et al. Atherosclerosis. 1976 Sep;24(3):407-19. doi: 10.1016/0021-9150(76)90133-7. Atherosclerosis. 1976. PMID: 971343 Clinical Trial.
The efficacy of an anion-exchange gel, Secholex, as a hypocholesterolemic agent was assessed in 46 patients in 4 different studies and the effects were compared with those of cholestyramine. All patients had severe Type II-a or II-b hyperlipoproteinemia. In short-term meta …
The efficacy of an anion-exchange gel, Secholex, as a hypocholesterolemic agent was assessed in 46 patients in 4 different studies and the e …
Randomized controlled trial of cholestyramine and hydrotalcite to eliminate bile for capsule endoscopy.
Hong-Bin C, Yue H, Chun H, Shu-Ping X, Yue Z, Xiao-Lin L. Hong-Bin C, et al. Saudi J Gastroenterol. 2016 Mar-Apr;22(2):122-6. doi: 10.4103/1319-3767.167185. Saudi J Gastroenterol. 2016. PMID: 26997218 Free PMC article. Clinical Trial.
BACKGROUND/AIMS: Bile is the main cause of poor bowel preparation for capsule endoscopy (CE). We aimed to determine whether cholestyramine and hydrotalcite can eliminate bile in the bowel. PATIENTS AND METHODS: Patients undergoing CE were randomized into two groups. ...Gro …
BACKGROUND/AIMS: Bile is the main cause of poor bowel preparation for capsule endoscopy (CE). We aimed to determine whether cholestyramin …
Lovastatin and simvastatin prevention studies.
Jones PH. Jones PH. Am J Cardiol. 1990 Sep 18;66(8):39B-43B. doi: 10.1016/0002-9149(90)90439-8. Am J Cardiol. 1990. PMID: 2206035 Review.
Two trials, the Lipid Research Clinics Coronary Primary Prevention Trial and the Helsinki Heart Study used cholestyramine and gemfibrozil, respectively, to alter lipoprotein levels; their demonstrated efficacy and safety have led to their widespread use in hyperlipidemic p …
Two trials, the Lipid Research Clinics Coronary Primary Prevention Trial and the Helsinki Heart Study used cholestyramine and gemfibr …
Adverse effects of hypolipidaemic drugs.
Knodel LC, Talbert RL. Knodel LC, et al. Med Toxicol. 1987 Jan-Feb;2(1):10-32. doi: 10.1007/BF03259858. Med Toxicol. 1987. PMID: 3547004 Review.
Cholestyramine, colestipol, clofibrate, gemfibrozil, nicotinic acid (niacin), probucol, neomycin, and dextrothyroxine are the most commonly used drugs in the treatment of hyperlipoproteinaemic disorders. ...Most significantly, osteomalacia and, on rare occasions, haemorrha …
Cholestyramine, colestipol, clofibrate, gemfibrozil, nicotinic acid (niacin), probucol, neomycin, and dextrothyroxine are the most co …
Clinical trial of a combination of rice bran fiber and cholestyramine for promotion of fecal excretion of retained polychlorinated dibenzofuran and polychlorinated biphenyl in Yu-Cheng patients.
Iida T, Nakagawa R, Hirakawa H, Matsueda T, Morita K, Hamamura K, Nakayama J, Hori Y, Guo YL, Chang FM, et al. Iida T, et al. Fukuoka Igaku Zasshi. 1995 May;86(5):226-33. Fukuoka Igaku Zasshi. 1995. PMID: 7628813 Clinical Trial.
A clinical trial using the combination of rice bran fiber (RBF) and cholestyramine (CHO) was carried out on Yu-Cheng patients in 1993-1994. ...
A clinical trial using the combination of rice bran fiber (RBF) and cholestyramine (CHO) was carried out on Yu-Cheng patients in 1993 …
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
Hagen E, Istad H, Ose L, Bodd E, Eriksen HM, Selvig V, Bard JM, Fruchart JC, Borge M, Wolf MC, et al. Hagen E, et al. Eur J Clin Pharmacol. 1994;46(5):445-9. doi: 10.1007/BF00191909. Eur J Clin Pharmacol. 1994. PMID: 7957541 Clinical Trial.
During the first 12 weeks of the study, fluvastatin (20 mg and 40 mg daily) was compared with cholestyramine (16 g per day). In the subsequent, 6-week part of the study, the comparative efficacy, safety and tolerability of 20 mg fluvastatin, combined with cholestyramine …
During the first 12 weeks of the study, fluvastatin (20 mg and 40 mg daily) was compared with cholestyramine (16 g per day). In the s …
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia.
Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Tonstad S, et al. J Pediatr. 1996 Jul;129(1):42-9. doi: 10.1016/s0022-3476(96)70188-9. J Pediatr. 1996. PMID: 8757561 Clinical Trial.
OBJECTIVE: To determine the efficacy and safety of cholestyramine therapy in young children with familial hypercholesterolemia. ...Folate deficiency may occur, even with a low dose of cholestyramine, and vitamin D supplements should be considered. Caution should pos …
OBJECTIVE: To determine the efficacy and safety of cholestyramine therapy in young children with familial hypercholesterolemia. ...Fo …
Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects.
Portincasa P, Di Ciaula A, Palmieri V, Van Berge-Henegouwen GP, Palasciano G. Portincasa P, et al. Eur J Clin Invest. 1995 Oct;25(10):746-53. doi: 10.1111/j.1365-2362.1995.tb01953.x. Eur J Clin Invest. 1995. PMID: 8557061 Clinical Trial.
Gastric emptying was delayed with cholestyramine in lean but not obese subjects. For the chronic study, after 1 month therapy with cholestyramine (4 g every 2 days), the motility tests were repeated in nine obese subjects. ...Cholestyramine may improve gallbl …
Gastric emptying was delayed with cholestyramine in lean but not obese subjects. For the chronic study, after 1 month therapy with …
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
Eriksson M, Hådell K, Holme I, Walldius G, Kjellström T. Eriksson M, et al. J Intern Med. 1998 May;243(5):373-80. doi: 10.1046/j.1365-2796.1998.00294.x. J Intern Med. 1998. PMID: 9651560 Free article. Clinical Trial.
After dietary intervention, an eligible patient was randomly assigned to one of four programs of daily treatment: group Q, 16 g cholestyramine, group QP, 8 g cholestyramine and 20 mg pravastatin, group P20, 20 mg pravastatin or group P40, 40 mg pravastatin. ...The d …
After dietary intervention, an eligible patient was randomly assigned to one of four programs of daily treatment: group Q, 16 g cholestyr …
406 results